The following video is from Thursday's edition of Investor Beat, in which host Chris Hill, and Motley Fool analysts Matt Koppenheffer and David Hanson, dissect the hardest-hitting investing stories of the day.
JPMorgan CEO Jamie Dimon met with Attorney General Eric Holder today, to discuss a possible settlement to end criminal and civil charges against the bank. The cost to JPMorgan, however, may be upwards of $11 billion. In today's lead story on Investor Beat, Matt and David discuss why a fine greater than an entire quarter of JPMorgan's earnings didn't drag down the stock, and whether they think this big bank is a buy today.
Then, the guys take a look at four stocks making big moves on the market today. Bed Bath & Beyond hits an all-time high after second-quarter profits rose 11%. Hertz takes a tumble after the company cut guidance for the rest of the year. J.C. Penney rebounds from its 13-year low yesterday, and was the most traded stock on Wall Street. And KiOR, a renewable fuels company based in Texas, is up huge today, on news that the company received a $50 million commitment from investor Vinod Khosla, intended to double the company's production capacity.
Finally, Matt and David tell investors why they'll be watching shares of Diamond Foods and Two Harbors Investment Corp this week.
Chris Hill has no position in any stocks mentioned. David Hanson owns shares of JPMorgan Chase & Co. Matt Koppenheffer owns shares of JPMorgan Chase & Co.. The Motley Fool recommends Bed Bath & Beyond. The Motley Fool owns shares of Hertz Global Holdings and JPMorgan Chase & Co. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Hate Checking Your Portfolio? Try These 2 High-Yield Stocks
If you agree with the notion that boring is good, then check out this energy company and this petroleum pipeline operator.
What Is a Family Limited Partnership?
Want a way to protect your family's wealth from the IRS? Enter the FLP.
Will This Tiny Biotech Be Celgene's Next Takeover Target?
Depending on data later this year, Celgene may want to buy this collaboration partner.